Literature DB >> 7128513

Risk of bilirubin acid precipitation in preterm infants with respiratory distress syndrome: considerations of blood/brain bilirubin transfer equilibrium.

F Ebbesen, R Brodersen.   

Abstract

Twenty-six preterm infants with respiratory distress syndrome (RDS), were examined daily during the first 6 days of life. Twenty-six equally preterm but clinically well infants served as controls. In the RDS infants, plasma albumin concentration was low, hyperbilirubinemia was prolonged, plasma pH was decreased during the first two days, and the concentration of reserve albumin for binding of monoacetyldiaminodiphenylsulfone (MADDS), a deputy ligand for bilirubin, was decreased on the second throughout the sixth day, when compared with the controls. These factors concur in increasing the likelihood of bilirubin acid precipitation in RDS above the increased risk present in preterm infants. The plasma of the preterm controls was supersaturated with respect to crystalline bilirubin acid by an average factor 5 (index of plasma bilirubin toxicity = 0.7) on the first day of life, peaking at a factor 10 (index 1.0) on the third and fourth days while these factors were 10 and 20 (index 1.0 and 1.3), respectively, in the RDS infants. Two of the latter surpassed a level of 60 times supersaturation (index 1.8) where acute precipitation of amorphous bilirubin acid becomes possible.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7128513     DOI: 10.1016/0378-3782(82)90072-x

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  7 in total

Review 1.  The blood-brain barrier and bilirubin encephalopathy.

Authors:  R P Wennberg
Journal:  Cell Mol Neurobiol       Date:  2000-02       Impact factor: 5.046

2.  Accuracy of transcutaneous bilirubin measurement in preterm low-birth-weight neonates.

Authors:  Deepak Chawla; Suksham Jain; Gurjit Kaur; Vikas Sinhmar; Vishal Guglani
Journal:  Eur J Pediatr       Date:  2013-08-17       Impact factor: 3.183

3.  Ceftriaxone--bilirubin-albumin interactions in the neonate: an in vivo study.

Authors:  E Martin; S Fanconi; P Kälin; C Zwingelstein; C Crevoisier; W Ruch; R Brodersen
Journal:  Eur J Pediatr       Date:  1993-06       Impact factor: 3.183

Review 4.  Treatment of jaundice in low birthweight infants.

Authors:  M J Maisels; J F Watchko
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-11       Impact factor: 5.747

5.  Bilirubin binding in premature infants from birth to 3 months.

Authors:  D A Ritter; J D Kenny
Journal:  Arch Dis Child       Date:  1986-04       Impact factor: 3.791

6.  Transcutaneous bilirubinometry in neonatal intensive care units.

Authors:  A Knudsen; F Ebbesen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-07       Impact factor: 5.747

7.  Newborn Metabolic Profile Associated with Hyperbilirubinemia With and Without Kernicterus.

Authors:  Molly E McCarthy; Scott P Oltman; Rebecca J Baer; Kelli K Ryckman; Elizabeth E Rogers; Martina A Steurer-Muller; John S Witte; Laura L Jelliffe-Pawlowski
Journal:  Clin Transl Sci       Date:  2018-10-28       Impact factor: 4.689

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.